Inventor · disambiguated record
Shinya Ishii
Also filed as: ISHII SHINYA
39 granted patents·31 pending applications·413 citations·filing 1979–2025
97Inventor score
Top patents by PatentIndex Score
70 records- 0198US8562991B2Antibody molecules that bind to IL-6 receptorIGAWA TOMOYUKI·Filed 2009·Granted Oct 22, 2013·130 cites·19 claims
- 0297US11371039B2Antigen-binding molecule capable of binding to two or more antigen molecules repeatedlyCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Granted Jun 28, 2022·4 cites·30 claims
- 0397US11359194B2Antigen-binding molecule capable of binding two or more antigen molecules repeatedlyCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Granted Jun 14, 2022·4 cites·29 claims
- 0497US10472623B2Antigen-binding molecule capable of binding two or more antigen molecules repeatedlyCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Nov 12, 2019·29 cites·21 claims
- 0597US9890377B2Antigen-binding molecule capable of binding to two or more antigen molecules repeatedlyCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Granted Feb 13, 2018·34 cites·24 claims
- 0696US10662245B2Methods of reducing IL-6 activity for disease treatmentCHUGAI PHARMACEUTICAL CO LTD·Filed 2014·Granted May 26, 2020·22 cites·25 claims
- 0796US9868948B2Antigen-binding molecule capable of binding to two or more antigen molecules repeatedlyCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Granted Jan 16, 2018·27 cites·34 claims
- 0893US2025101118A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0992US10024867B2Ion concentration-dependent binding molecule libraryCHUGAI PHARMACEUTICAL CO LTD·Filed 2012·Granted Jul 17, 2018·24 cites·18 claims
- 1092US2025346677A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1191US11891434B2Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedlyCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Feb 6, 2024·6 cites·32 claims
- 1291US2024301075A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1388US2024010738A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1487US8010516B2Content sharing system and content importance level judging methodSONY CORP·Filed 2005·Granted Aug 30, 2011·19 cites·30 claims
- 1586US2024002836A1Antigen-binding molecule capable of binding to two or more antigen molecules repeatedlyCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1686US2023159648A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1785US10139245B2Device for providing electric-moving-body information and method for providing electric-moving-body informationMITSUBISHI HEAVY IND LTD·Filed 2017·Granted Nov 27, 2018·6 cites·10 claims
- 1884US11667713B2Cytotoxicity-inducing therapeutic agentCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Jun 6, 2023·3 cites·14 claims
- 1984US7839405B2Apparatus, method, and program for projection of 3D spatial image into planar images using visual pointsSONY CORP·Filed 2007·Granted Nov 23, 2010·7 cites·8 claims
- 2083US2022306755A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2182US10501737B2Method for producing antigen-binding molecule using modified helper phageCHUGAI PHARMACEUTICAL CO LTD·Filed 2014·Granted Dec 10, 2019·3 cites·14 claims
- 2282US7724250B2Apparatus, method, and program for processing informationSONY CORP·Filed 2003·Granted May 25, 2010·35 cites·24 claims
- 2382US2023220083A1Antibodies with modified affinity to fcrn that promote antigen clearanceCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2480US2022041741A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2579US9183798B2Image capture apparatus that increases white pixel display luminance during image capture modeCANON KK·Filed 2013·Granted Nov 10, 2015·3 cites·18 claims
- 2678US2024158482A1Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedlyCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 2776US12479915B2Cytotoxicity-inducing therapeutic agentCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Nov 25, 2025·0 cites·31 claims
- 2874US8908720B2Directed-energy irradiating apparatusMITSUBISHI HEAVY IND LTD·Filed 2013·Granted Dec 9, 2014·5 cites·19 claims
- 2974US2020231688A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 3072US2022187308A1Ion concentration-dependent binding molecule libraryCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 3171US11022839B2Display apparatus configured to display input image and graphic image and method for controlling sameCANON KK·Filed 2018·Granted Jun 1, 2021·1 cites·20 claims
- 3270US7773641B2Optically pumped disk-type solid state laser oscillator and optically pumped disk-type solid state laser systemMITSUBISHI HEAVY IND LTD·Filed 2007·Granted Aug 10, 2010·3 cites·6 claims
- 3370US2020048627A1Antigen-binding molecule capable of binding to two or more antigen molecules repeatedlyCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 3470US2023203144A1Combination of two or more anti-c5 antibodies and methods of useCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 3569US2011111406A1Antigen-binding molecule capable of binding to two or more antigen molecules repeatedlyCHUGAI PHARMACEUTICAL CO LTD·Filed 2009·Application pending·0 cites
- 3667US7411617B2Image processing apparatus, image processing method, recording medium, and programSONY CORP·Filed 2003·Granted Aug 12, 2008·8 cites·12 claims
- 3766US2017002080A1Antibodies With Modified Affinity To FcRn That Promote Antigen ClearanceCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 3865US8259763B2Laser gain medium and laser oscillator using the sameTAKESHITA KENJI·Filed 2011·Granted Sep 4, 2012·2 cites·9 claims
- 3965US6753932B2Method and apparatus for controlling convergence of color signalsSONY CORP·Filed 2001·Granted Jun 22, 2004·6 cites·9 claims
- 4064US2017226206A1Antibodies With Modified Affinity To FcRn That Promote Antigen ClearanceCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 4163US11243210B2Ion concentration-dependent binding molecule libraryCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Feb 8, 2022·0 cites·11 claims
- 4263US6635125B2Grain-oriented electrical steel sheet excellent in film characteristics and magnetic characteristics, process for producing same, and decarburization annealing facility used in same processNIPPON STEEL CORP·Filed 2002·Granted Oct 21, 2003·6 cites·2 claims
- 4363US2017002066A1Antibodies With Modified Affinity To FcRn That Promote Antigen ClearanceCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 4463US2013011866A1Antigen-binding molecule capable of binding to two or more antigen molecules repeatedlyCHUGAI PHARMACEUTICAL CO LTD·Filed 2012·Application pending·0 cites
- 4563US2012253016A1Antibody molecules that bind to il-6 receptorIGAWA TOMOYUKI·Filed 2012·Application pending·0 cites
- 4662US2016244526A1Antibodies with modified affinity to fcrn that promote antigen clearanceCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 4761US8068523B2Laser gain medium and laser oscillator using the sameTAKESHITA KENJI·Filed 2009·Granted Nov 29, 2011·2 cites·6 claims
- 4860US2013131319A1Antibodies with modified affinity to fcrn that promote antigen clearanceIGAWA TOMOYUKI·Filed 2011·Application pending·0 cites
- 4956US2024425589A1Cytotoxicity-inducing therapeutic agent for use in treatment of cancerCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 5055US2014234340A1Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedlyIGAWA TOMOYUKI·Filed 2011·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Shinya Ishii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →